Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUPROPION Cause Insurance issue? 113 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Insurance issue have been filed in association with BUPROPION (Bupropion Hydrochloride (XL)). This represents 0.3% of all adverse event reports for BUPROPION.

113
Reports of Insurance issue with BUPROPION
0.3%
of all BUPROPION reports
4
Deaths
15
Hospitalizations

How Dangerous Is Insurance issue From BUPROPION?

Of the 113 reports, 4 (3.5%) resulted in death, 15 (13.3%) required hospitalization.

Is Insurance issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUPROPION. However, 113 reports have been filed with the FAERS database.

What Other Side Effects Does BUPROPION Cause?

Completed suicide (5,095) Drug ineffective (3,991) Toxicity to various agents (3,837) Depression (2,486) Overdose (2,357) Headache (2,323) Anxiety (2,145) Intentional overdose (2,103) Drug hypersensitivity (1,967) Seizure (1,894)

What Other Drugs Cause Insurance issue?

CERTOLIZUMAB PEGOL (1,210) HUMAN IMMUNOGLOBULIN G (1,090) LISDEXAMFETAMINE DIMESYLATE (590) RIFAXIMIN (577) LENALIDOMIDE (376) ARIPIPRAZOLE (345) HUMAN C1-ESTERASE INHIBITOR (295) HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (253) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (227) ETANERCEPT (220)

Which BUPROPION Alternatives Have Lower Insurance issue Risk?

BUPROPION vs BUPROPION HYDROBROMIDE BUPROPION vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE BUPROPION vs BUPROPION\NALTREXONE BUPROPION vs BUROSUMAB BUPROPION vs BUROSUMAB-TWZA

Related Pages

BUPROPION Full Profile All Insurance issue Reports All Drugs Causing Insurance issue BUPROPION Demographics